Clinical Trials for Hemogenyx Pharmaceuticals

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Hemogenyx Pharmaceuticals

Clinical Trials (1)

NCT06786533
Clinical Study of Anti-FLT3 CAR-T Cells for the Treatment of Relapsed/Refractory AML
PHASE1Recruiting
18 participants
Started: Jan 23, 2025 · Completed: Jan 31, 2027
1 condition2 sponsors1 location